IL1R1 and aspergillosis: IL-1Ra, by competitive binding of IL-1 type 1 receptor (IL-1R), can be an immunomodulatory strategy for fungal infections where disease and pathology are the result of inflammation-driven collateral damage (e.g. VVC, pulmonary aspergillosis, or influenza-associated pulmonary aspergillosis).